On 1st December 2021, IDEA-FAST invited its consortium members to join an internal Science Showcase. The aim of the Science Showcase was to review the Feasibility Study (FS) data and brainstorm the next analysis steps in a clinical context and in the light of the feedback we have received from European Medicines Agency (EMA) on the process for qualification of digital endpoints. The event was well attended by project partners, counting 79 attendees, and stimulated discussion on the topics of outcomes and clinical insights from the FS, including a polysomnography sub-study, integrated analytics, digital devices and technology and device data analytics. Members of the Scientific Advisory Board were also present and provided insightful feedback to guide the further development of the project.
